trn-157
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2014 (NCT02133339)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trn-157
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02382510 | Phase 2 | Apr 1, 2015 | Theron Pharmaceuticals, Inc. |
| NCT02133339 | Phase 1 | May 1, 2014 | Theron Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Theron Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2014 |
1 organizations
Page 1 / 1